Cancer cells, on your histone marks, get SETDB1, silence retrotransposons, and go!
- PMID: 29066607
- PMCID: PMC5674904
- DOI: 10.1083/jcb.201710068
Cancer cells, on your histone marks, get SETDB1, silence retrotransposons, and go!
Abstract
Cancer cells thrive on genetic and epigenetic changes that confer a selective advantage but also need strategies to avoid immune recognition. In this issue, Cuellar et al. (2017. J. Cell Biol https://doi.org/10.1083/jcb.201612160) find that the histone methyltransferase SETDB1 enables acute myeloid leukemia cells to evade sensing of retrotransposons by innate immune receptors.
© 2017 Robbez-Masson et al.
Figures
Comment on
-
Silencing of retrotransposons by SETDB1 inhibits the interferon response in acute myeloid leukemia.J Cell Biol. 2017 Nov 6;216(11):3535-3549. doi: 10.1083/jcb.201612160. Epub 2017 Sep 8. J Cell Biol. 2017. PMID: 28887438 Free PMC article.
References
-
- Chiappinelli K.B., Strissel P.L., Desrichard A., Li H., Henke C., Akman B., Hein A., Rote N.S., Cope L.M., Snyder A., et al. 2015. Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses. Cell. 162:974–986. 10.1016/j.cell.2015.07.011 - DOI - PMC - PubMed
-
- Guler G.D., Tindell C.A., Pitti R., Wilson C., Nichols K., KaiWai Cheung T., Kim H.J., Wongchenko M., Yan Y., Haley B., et al. 2017. Repression of Stress-Induced LINE-1 Expression Protects Cancer Cell Subpopulations from Lethal Drug Exposure. Cancer Cell. 32:221–237.e13. 10.1016/j.ccell.2017.07.002 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
